Radiation Recall Phenomenon: A Literature Review
Sari
The radiation recall phenomenon is an inflammatory reaction on a previously irradiated area of the body that occurs due to exposure to triggering agents. In cancer settings, radiotherapy is often followed by chemotherapy or other systemic therapies, and this combination can trigger the radiation recall phenomenon. The triggering agents associated with this reaction are generally cytotoxic (e.g., chemotherapy); however, other agents usage has been widely reported. This reaction manifested in various areas of the body, with the skin being the most predilection site. There is no absolute range of radiation doses associated with this reaction. The interaction among radiotherapy components, triggering agents, and time of the agent’s initiation influences the risk and onset of this phenomenon. Although known for a long time, the mechanism is ambiguous. A series of hypothetical theories are described, including their relation to stem cell function and sensitivity, vascular damage, and drug hypersensitivity reactions. Management of this reaction may include modifying triggering agents, administration of steroids, and other symptomatic therapies. In severe cases, surgical intervention can be performed. Comprehensive observational or even experimental databases are needed for this phenomenon to be entirely understood.
Kata Kunci
Teks Lengkap:
PDF (English)Referensi
D’Angio GJ, Farber S, Maddock CL. Potentiation of X-Ray Effects by Actinomycin D. Radiology. 1959 Aug;73(2):175–7.
Burris HA, Hurtig J. Radiation Recall with Anticancer Agents. The Oncologist. 2010 Nov;15(11):1227–37.
Langer SW. A Recall Reaction and Call for Action. Onkologie. 2010;33(3):85–6.
Kodym E, Kalinska R, Ehringfeld C, Sterbik-Lamina A, Kodym R, Hohenberg G. Frequency of Radiation Recall Dermatitis in Adult Cancer Patients. Oncol Res Treat. 2005;28(1):18–21.
Harsh KK, Kapoor A, Purohit R, Kumari S, Nirban RK, Kumar HS. Radiation Recall Dermatitis Patterns in Carcinoma Breast: 7-Years Experience of A Regional Cancer Centre of North West India. Austral-Asian J Cancer. 2014 Oct;13(4):179–84.
Mizumoto M, Harada H, Asakura H, Zenda S, Fuji H, Murayama S, et al. Frequency and characteristics of docetaxel-induced radiation recall phenomenon. Int J Radiat Oncol. 2006 Nov;66(4):1187–91.
Shimokawaji T, Narita S, Naito T, Udagawa H, Goto K, Miyawaki T, et al. Clinical characteristics of nivolumab-induced radiation recall pneumonitis in patients with non-small cell lung cancer: A multicenter real-world analysis of 669 patients. J Clin Oncol. 2020 Feb 10;38(5_suppl):88–88.
Caloglu M, Yurut-Caloglu V, Cosar-Alas R, Saynak M, Karagol H, Uzal C. An Ambiguous Phenomenon of Radiation and Drugs: Recall Reactions. Oncol Res Treat. 2007;30(4):209–14.
Camidge R, Price A. Characterizing the phenomenon of radiation recall dermatitis. Radiother Oncol. 2001 Jun;59(3):237–45.
Benyounes A, Pathak A, Binder EL, Hausner PF. An attempt to better understand radiation recall events: A literature review. J Clin Oncol. 2018 May 20;36(15_suppl):e22109–e22109.
Azria D, Magné N, Zouhair A, Castadot P, Culine S, Ychou M, et al. Radiation recall: A well recognized but neglected phenomenon. Cancer Treat Rev. 2005 Nov;31(7):555–70.
LaCouture T. Radiation Recall (radiation dermatitis, recall phenomenon) ICD-9 990 [Internet]. Dermatology Advisor. 2017. Available from: https://www.dermatologyadvisor.com/home/decision-support-in-medicine/dermatology/radiation-recall-radiation-dermatitis-recall-phenomenon-icd-9-990/
Hellman S, Botnick LE. Stem cell depletion: An explanation of the late effects of cytotoxins. Int J Radiat Oncol. 1977 Jan;2(1–2):181–4.
Seymour CB, Mothersill C, Alper T. High Yields of Lethal Mutations in Somatic Mammalian Cells that Survive Ionizing Radiation. Int J Radiat Biol Relat Stud Phys Chem Med. 1986 Jan;50(1):167–79.
Abadir R, Liebmann J. Radiation reaction recall following simvastatin therapy: A new observation. Clin Oncol. 1995 Jan;7(5):325–6.
Kitani H, Kosaka T, Fujihara T, Lindquist K, Elkind MM. The “recall effect” in radiotherapy: Is subeffective, reparable damage involved? Int J Radiat Oncol. 1990 Mar;18(3):689–95.
Dimitrievich GS, Fischer-Dzoga K, Griem ML. Radiosensitivity of Vascular Tissue: I. Differential Radiosensitivity of Capillaries: A Quantitative in Vivo Study. Radiat Res. 1984 Sep;99(3):511.
Baselet B, Sonveaux P, Baatout S, Aerts A. Pathological effects of ionizing radiation: endothelial activation and dysfunction. Cell Mol Life Sci. 2019 Feb;76(4):699–728.
Wintroub BU, Stern R. Cutaneous drug reactions: Pathogenesis and clinical classification. J Am Acad Dermatol. 1985 Aug;13(2):167–79.
Scher N, Vozenin MC, Bouchaab H, Ozsahin M, Bourhis J. Isodose 20 Gy found as a threshold dose for radiation recall dermatitis. Clin Transl Radiat Oncol. 2019 Jul;17:14–6.
Kj S, Tw G, Wj K. Radiation recall skin toxicity with bleomycin in a patient with Kaposi sarcoma related to acquired immune deficiency syndrome. Cancer. 1993 Feb 1;71(4):1322–5.
Mallik S, Gupta S, Munshi A. Memoirs of differential radiation doses: Gemcitabine induced radiation recall. Acta Oncol. 2010 Jan;49(2):261–2.
Sakaguchi M, Maebayashi T, Aizawa T, Ishibashi N. Docetaxel-induced radiation recall dermatitis with atypical features: A case report. Medicine (Baltimore). 2018 Sep;97(36):e12209.
Sroa N, Bartholomew DA, Magro CM. Lipodermatosclerosis as a form of vascular compromise-associated radiation recall dermatitis: case report and a review of literature. J Cutan Pathol. 2006 Sep;33(s2):55–9.
Yeo W, Johnson PJ. Radiation-recall skin disorders associated with the use of antineoplastic drugs. Pathogenesis, prevalence, and management. Am J Clin Dermatol. 2000 Apr;1(2):113–6.
Taunk NK, Haffty BG, Goyal S. Radiation Recall 5 Years After Whole-Breast Irradiation for Early-Stage Breast Cancer Secondary to Initiation of Rosuvastatin and Amlodipine. J Clin Oncol. 2011 Aug 1;29(22):e661–3.
D’Orazio J, Jarrett S, Amaro-Ortiz A, Scott T. UV Radiation and the Skin. Int J Mol Sci. 2013 Jun 7;14(6):12222–48.
Tlougan BE, Mancini AJ, Mandell JA, Cohen DE, Sanchez MR. Skin Conditions in Figure Skaters, Ice-Hockey Players and Speed Skaters: Part II – Cold-Induced, Infectious and Inflammatory Dermatoses. Sports Med. 2011 Nov;41(11):967–84.
Landy RE, Stross WC, May JM, Kaleem TA, Malouff TD, Waddle MR, et al. Idiopathic mast cell activation syndrome and radiation therapy: a case study, literature review, and discussion of mast cell disorders and radiotherapy. Radiat Oncol. 2019 Dec;14(1):222.
Smith KJ, Germain M, Skelton H. Histopathologic Features Seen with Radiation Recall or Enhancement Eruptions. J Cutan Med Surg Inc Med Surg Dermatol. 2002 Dec 1;6(6):535–40.
Tetreault-Laflamme A, Bachand F. Grade 3 Radiation Recall Sigmoiditis after Treatment for Locally Advanced Cervical Cancer: A Case Report. Cureus [Internet]. 2015 Oct 15 [cited 2020 Oct 11]; Available from: http://www.cureus.com/articles/3395-grade-3-radiation-recall-sigmoiditis-after-treatment-for-locally-advanced-cervical-cancer-a-case-report
McGovern K, Ghaly M, Esposito M, Barnaby K, Seetharamu N. Radiation recall pneumonitis in the setting of immunotherapy and radiation: a focused review. Future Sci OA. 2019 Jun;5(5):FSO378.
DOI: https://doi.org/10.32532/jori.v12i2.134 <
Article metrics
Abstract views : 376 | views : 332Refbacks
- Saat ini tidak ada refbacks.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.